These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Vitner EB; Dekel H; Zigdon H; Shachar T; Farfel-Becker T; Eilam R; Karlsson S; Futerman AH Hum Mol Genet; 2010 Sep; 19(18):3583-90. PubMed ID: 20616152 [TBL] [Abstract][Full Text] [Related]
4. Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant. Pàmpols T; Pineda M; Girós ML; Ferrer I; Cusi V; Chabás A; Sanmarti FX; Vanier MT; Christomanou H Acta Neuropathol; 1999 Jan; 97(1):91-7. PubMed ID: 9930900 [TBL] [Abstract][Full Text] [Related]
5. A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse. Willemsen R; Tybulewicz V; Sidransky E; Eliason WK; Martin BM; LaMarca ME; Reuser AJ; Tremblay M; Westphal H; Mulligan RC Mol Chem Neuropathol; 1995; 24(2-3):179-92. PubMed ID: 7632321 [TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; Gaucher disease]. Hollak CE; Boot RG; Poorthuis BJ; Aerts JM Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076 [TBL] [Abstract][Full Text] [Related]
7. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease. McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760 [TBL] [Abstract][Full Text] [Related]
8. Recent advances and novel treatments for sphingolipidoses. Arenz C Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617 [TBL] [Abstract][Full Text] [Related]
9. [Molecular diagnosis and gene therapy for Gaucher disease]. Ohashi T Nihon Rinsho; 1993 Sep; 51(9):2300-7. PubMed ID: 8411706 [TBL] [Abstract][Full Text] [Related]
10. Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease. Sinclair GB; Jevon G; Colobong KE; Randall DR; Choy FY; Clarke LA Mol Genet Metab; 2007 Feb; 90(2):148-56. PubMed ID: 17079175 [TBL] [Abstract][Full Text] [Related]